These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
858 related items for PubMed ID: 15761375
41. Control of HIV-1 replication by RNA interference. Lee NS, Rossi JJ. Virus Res; 2004 Jun 01; 102(1):53-8. PubMed ID: 15068880 [Abstract] [Full Text] [Related]
42. [RNA interference and its possible use in cancer therapy]. Ait-Si-Ali S, Guasconi V, Harel-Bellan A. Bull Cancer; 2004 Jan 01; 91(1):15-8. PubMed ID: 14975801 [Abstract] [Full Text] [Related]
43. Genome-wide application of RNAi to the discovery of potential drug targets. Ito M, Kawano K, Miyagishi M, Taira K. FEBS Lett; 2005 Oct 31; 579(26):5988-95. PubMed ID: 16153642 [Abstract] [Full Text] [Related]
44. Downregulation enhanced green fluorescence protein gene expression by RNA interference in mammalian cells. Zhang M, Bai CX, Zhang X, Chen J, Mao L, Gao L. RNA Biol; 2004 May 31; 1(1):74-7. PubMed ID: 17194936 [Abstract] [Full Text] [Related]
45. [Gene silencing RNAi technology: possible application to therapy]. Vestin A, Weinstein J, Davidov E, Sidi Y, Yakobson EA. Harefuah; 2006 Feb 31; 145(2):156-9, 163. PubMed ID: 16509424 [Abstract] [Full Text] [Related]
46. RNA silencing platforms in plants. Watson JM, Fusaro AF, Wang M, Waterhouse PM. FEBS Lett; 2005 Oct 31; 579(26):5982-7. PubMed ID: 16139270 [Abstract] [Full Text] [Related]
47. [Application of RNAi technology to knockdown gene expression in vivo in mammalians]. Zhang AH, Liu GQ. Sheng Li Ke Xue Jin Zhan; 2004 Apr 31; 35(2):125-9. PubMed ID: 15285417 [Abstract] [Full Text] [Related]
54. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Luo Q, Kang Q, Song WX, Luu HH, Luo X, An N, Luo J, Deng ZL, Jiang W, Yin H, Chen J, Sharff KA, Tang N, Bennett E, Haydon RC, He TC. Gene; 2007 Jun 15; 395(1-2):160-9. PubMed ID: 17449199 [Abstract] [Full Text] [Related]
57. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Akhtar S, Benter I. Adv Drug Deliv Rev; 2007 Mar 30; 59(2-3):164-82. PubMed ID: 17481774 [Abstract] [Full Text] [Related]
58. Transcriptional gene silencing by short interfering RNAs. Kawasaki H, Taira K. Curr Opin Mol Ther; 2005 Apr 30; 7(2):125-31. PubMed ID: 15844619 [Abstract] [Full Text] [Related]
59. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, Hartmann R, Fujita T, Behlke MA, Williams BR. Nat Biotechnol; 2006 May 30; 24(5):559-65. PubMed ID: 16648842 [Abstract] [Full Text] [Related]